Implantica AG (OSTO:IMP A SDB) OCF Margin %: 0.00% (As of . 20)


OSTO:IMP A SDB Implantica AG OSTO:IMP A SDB
26 GF Score
Price kr61.90
View Full Analysis

What is Implantica AG OCF Margin %?

Implantica AG OSTO:IMP A SDB -0.80% 26 OCF Margin % is 0.00% as of . 20. GuruFocus rates OSTO:IMP A SDB with a GF Score™ of 26/100. Among 815 Medical Devices & Instruments companies, Implantica AG ranks worse than 122699.26% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Implantica AG's Cash Flow from Operations for the six months ended in . 20 was kr0.00 Mil. Implantica AG's Revenue for the six months ended in . 20 was kr0.00 Mil. Therefore, Implantica AG's OCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Implantica AG's current OCF Yield % is 0.00%.

The historical rank and industry rank for Implantica AG's OCF Margin % or its related term are showing as below:


OSTO:IMP A SDB's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86
* Ranked among companies with meaningful OCF Margin % only.

Implantica AG OCF Margin % Related Terms

Implantica AG OCF Margin % Historical Data

* Premium members only.

The historical data trend for Implantica AG's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG OCF Margin % Chart

Implantica AG Annual Data
Trend
OCF Margin %

Implantica AG Semi-Annual Data
OCF Margin %
OSTO:IMP A SDB
26GF Score
Implantica AG OSTO:IMP A SDB
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implantica AG OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Implantica AG's OCF Margin for the fiscal year that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (A: . 20 )/Revenue (A: . 20 )
=/
= %

Implantica AG's OCF Margin for the quarter that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Implantica AG (OSTO:IMP A SDB) has a OCF Margin % of 0.00% as of . 20. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Implantica AG's OCF Margin % too high?
Implantica AG's current OCF Margin % is 0.00%. Based on the distribution chart, Implantica AG ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's OCF Margin % compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 815 companies for OCF Margin %. This places Implantica AG in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (OSTO:IMP A SDB) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Implantica AG's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Implantica AG (OSTO:IMP A SDB), the current OCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
26GF Score

Get the complete analysis for OSTO:IMP A SDB

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr61.90
Price